Philadelphia Pharmaceuticals Company (ASE:PHIL)
1.900
-0.030 (-1.55%)
At close: Aug 30, 2026
| Market Cap | 14.25M +30.1% |
| Revenue (ttm) | 8.97M -2.3% |
| Net Income | 1.06M +15.9% |
| EPS | 0.14 +15.9% |
| Shares Out | 7.50M |
| PE Ratio | 13.44 |
| Forward PE | n/a |
| Dividend | 0.07 (3.68%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 1,275 |
| Open | 1.930 |
| Previous Close | 1.930 |
| Day's Range | 1.900 - 1.930 |
| 52-Week Range | 1.480 - 2.010 |
| Beta | -0.04 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 29, 2026 |